The waiting room at Progressive Medical Research (PMR) doesn’t feel like a laboratory lobby. There is no clinical chill or sense of transience. Instead, it feels lived-in, like a place where people know one another’s names. The hum of quiet conversation filters through from the hallway, where nurses pass by with the easy familiarity of colleagues who have worked together for decades.
That warm and personal atmosphere is the heartbeat of the company and, in many ways, the reason why it continues to thrive.
PMR is not a corporate network or a slick acquisition built for scale. It is physician-founded, family-owned, and deeply rooted in the Florida community it serves.
The company’s CEO and founder, Alexander White, MD, has been in clinical research for nearly three decades. What began as a small, independent site has evolved into one of the region’s most trusted full-phase research centers, conducting everything from early Phase I safety studies to long-term, multi-center trials.
Basil White, COO and brother; Alexandra Zachos, Director of Public Affairs and Programs and cousin; and their mother, Katherine White, have all been essential in supporting Dr. White in achieving his mission.
“We’ve stayed small enough to care, but experienced enough to make an impact,” he says.
That philosophy sets PMR apart in an industry increasingly driven by scale rather than personal care.
A Legacy of Independence
The company’s independence is no small thing. Across the country, many clinical research sites have merged into larger corporate networks. PMR has chosen a different path—one that preserves agility, trust, and meaningful relationships.
Many members of the staff have worked together for more than twenty years, creating a level of continuity that directly impacts the quality of care and research.
Patients notice the difference immediately. They are greeted by name, not by file number, and are given time to ask questions. Many stay in touch long after their studies end, and some even refer friends and family. That kind of trust is built over time, through genuine connection.
The People Behind the Practice
If the research industry were a family tree, PMR would be the branch that never forgot its roots.
Dr. White began his career in emergency medicine, a background that continues to shape his clinical instincts. Two of his longtime colleagues, Dr. Mohamed, his former intern, and physician assistant Richard Marshall, share that same emergency care foundation, reinforcing a strong culture of safety and preparedness.
Because the site conducts Phase I trials, where safety is paramount, PMR maintains hospital-level readiness, including emergency protocols, crash carts, and direct connections to local health systems such as Halifax Health and AdventHealth.
But beyond clinical excellence, it is the team’s compassion that defines the culture. One retired nurse, Julie, who spent years coordinating Alzheimer’s studies, once took an elderly patient into her home during a hurricane—simply because it felt like the right thing to do. Stories like this quietly reflect the heart of the organization.
Trials With Purpose
PMR conducts studies across a wide range of therapeutic areas, including cardiovascular disease, diabetes, MASH (fatty liver disease), and metabolic disorders. The site is particularly known for its work in neuroscience, especially Alzheimer’s research.
With the addition of Dr. Visvalingam, a hematologist and oncologist, PMR is now expanding into immunology and oncology.
“We live in a community with a large aging population,” Dr. White has said. “You can’t ignore that. You have to meet it.”
Under his leadership, PMR has participated in pivotal studies that helped bring the first disease-modifying Alzheimer’s treatments to market. The team also leads studies focused on early detection, using advanced tools to identify cognitive decline before symptoms appear.
That responsiveness extends directly from the community. When members of a local Parkinson’s boxing group began asking about new treatment options, PMR responded by securing a Phase I study focused on potential disease-modifying therapies.
Speed, Quality, and a Human Touch
Sponsors consistently describe PMR as efficient, responsive, and easy to work with. Without the layers of a large corporate structure, the team can move quickly while maintaining high standards.
In one instance, a biotech company needed to meet a critical enrollment milestone by a specific date. PMR delivered, helping keep the study—and its potential impact—on track.
Behind the scenes, quality control is constant. Data is reviewed daily, documentation is meticulous, and regulatory files are maintained to the highest standards. The site welcomes audits and treats monitors as collaborators, creating a process that is both thorough and transparent.
Community as Mission
PMR’s commitment extends well beyond clinical research.
Dr. White founded the nonprofit Giving a Reason for Hope, which supports individuals and families facing financial hardship by helping with rent, utilities, and other essential needs.
The organization also supports local programs that offer second chances to individuals reentering the workforce and promotes wellness initiatives such as the Parkinson’s boxing group Rock Solid Boxing.
PMR is also dedicated to mentorship, welcoming interns from Bethune-Cookman University and other local institutions. Many go on to pursue careers in medicine or research, while others establish their own practices—extending PMR’s impact even further.
Doing Research the Right Way
PMR’s approach is rooted in precision and integrity. The regulatory department, led by longtime head Jacqulyn, is known for its meticulous attention to detail.
This commitment has earned the site strong recognition from sponsors across key performance metrics, including startup timelines, responsiveness, and compliance.
But beyond the numbers, what stands out is the way the team works—with coordination, pride, and genuine care for both patients and research outcomes.
Developing Standards for Digital Endpoints
Looking ahead, PMR continues to expand its reach and innovation.
Plans are underway for a new facility in an underserved area of Daytona Beach, offering free health screenings, education, and expanded access to clinical trials.
The team is also exploring digital tools for early detection of cognitive decline, working alongside healthcare systems and technology partners to bring these advancements into both research and patient care.
Dr. White’s involvement in developing standards for digital endpoints in Alzheimer’s research reflects the growing influence of PMR beyond its local footprint.
